Epstein-Barr virus and gastric carcinoma--viral carcinogenesis through epigenetic mechanisms.
Epstein-Barr virus (EBV)-associated gastric carcinoma (GC) is the monoclonal growth of EBV-infected epithelial cells, and the entity was recognized only recently. EBV-associated GC is distributed worldwide and more than 90,000 patients are estimated to develop GC annually in association with EBV (10% of total GC). EBV-associated GC occurs in two forms in terms of the histological features, i.e., lymphoepithelioma-like GC and ordinary type of GC. Both share characteristic clinicopathological features, such as the preferential occurrence as multiple cancer and remnant stomach cancer. While the expression of EBV-latent genes is restricted to several in the infected cells (Latency I), EBV-associated GC shows gastric cell phenotype, resistance to apoptosis, and the production of immunomodulator molecules. Recently, global and non-random CpG island methylation of the promoter region of many cancer-related genes has been demonstrated with their decreased expression, such as p16 INK4A, p73 and E-cadherin. This abnormality is accompanied by methylation of the EBV genome itself, suggesting a process of virus-driven hypermethylation in the development of neoplastic cells. Further studies are necessary to determine the precise sequence of EBV infection, methylation, transformation and selection of the predominant clone within the stomach mucosa. Future studies are also desirable for the target and strategy of therapy, such as initiating viral replication or reversing the DNA methylation of cellular genes.
Uozaki
Hiroshi
H
Department of Pathology, Graduate School of Medicine, The University of Tokyo Bunkyo-ku, Tokyo, Japan.
Fukayama
Masashi
M
Clin Cancer Res. 2006 May 15;12(10):2995-3002
16707594
J Clin Oncol. 2004 Feb 15;22(4):664-70
14966089
Blood. 1996 Oct 15;88(8):3129-36
8874213
J Virol. 1998 May;72(5):4371-8
9557727
J Virol. 1997 Jul;71(7):5688-91
9188650
Adv Cancer Res. 2003;89:133-56
14587872
Gastroenterology. 2005 Dec;129(6):2058-63
16344071
World J Gastroenterol. 2006 Aug 21;12(31):4959-65
16937490
Diagn Mol Pathol. 2002 Sep;11(3):127-34
12218450
Cancer Res. 1999 Nov 1;59(21):5438-42
10554013
J Med Virol. 1999 Feb;57(2):152-8
9892400
Int J Cancer. 2007 Jan 1;120(1):60-6
17058198
J Clin Invest. 1999 Jul;104(2):163-71
10411545
Int J Cancer. 1997 Aug 22;74(4):450-4
9291438
Jpn J Cancer Res. 2002 Nov;93(11):1195-200
12460459
Oncology. 2002;62(1):60-5
11810045
Blood. 1996 Feb 15;87(4):1579-85
8608250
J Cancer Res Clin Oncol. 1996;122(12):750-6
8954173
J Gastroenterol Hepatol. 1998 Jun;13(6):585-90
9715400
Int J Cancer. 1996 May 29;66(5):711-2
8647637
Int J Gastrointest Cancer. 2003;34(2-3):87-94
15361640
Virology. 2004 Mar 15;320(2):330-6
15016554
Clin Cancer Res. 2004 Mar 1;10(5):1698-705
15014022
Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8681-6
10411935
Microsc Res Tech. 2001 Jun 15;53(6):409-13
11525258
J Virol. 1996 Aug;70(8):5557-63
8764069
Curr Top Microbiol Immunol. 2001;258:91-102
11443869
Am J Clin Pathol. 1991 Aug;96(2):219-27
1650533
Oncogene. 1997 Jun 26;14(25):3073-81
9223671
Pathol Int. 1997 Oct;47(10):730-4
9361110
Histopathology. 1998 Oct;33(4):311-7
9822919
Am J Pathol. 1993 Oct;143(4):1063-71
8214002
Gastric Cancer. 1999 Aug;2(2):101-108
11957081
Hokkaido Igaku Zasshi. 1995 Sep;70(5):729-42
8543279
J Infect Dis. 2002 Jan 1;185(1):106-9
11756988
Mod Pathol. 1990 May;3(3):377-80
2163534
Cancer Res. 2002 Nov 15;62(22):6645-50
12438262
J Gastroenterol. 2005 Jun;40(6):570-7
16007390
Int J Cancer. 2006 Apr 1;118(7):1736-42
16217758
Gastroenterology. 2000 Jun;118(6):1031-8
10833477
Am J Pathol. 1991 Sep;139(3):469-74
1653517
Cancer. 1996 May 15;77(10):1998-2004
8640662
Histopathology. 2007 Jan;50(1):113-30
17204026
Cell. 1987 Jul 17;50(2):203-13
3036369
J Virol. 2003 Nov;77(22):12276-84
14581564
Cancer Res. 2000 May 15;60(10):2745-8
10825150
Histopathology. 1999 Jun;34(6):502-9
10383694
J Clin Pathol. 2002 Sep;55(9):669-75
12194996
Cancer Epidemiol Biomarkers Prev. 1998 May;7(5):449-50
9610796
Gastroenterology. 2001 Sep;121(3):612-8
11522745
Cancer Res. 1994 Sep 1;54(17):4595-7
8062248
Int J Cancer. 1997 Jul 3;72(1):72-6
9212226
Clin Immunol. 2003 Oct;109(1):53-63
14585276
Am J Pathol. 2004 Feb;164(2):689-99
14742272
Gastrointest Endosc. 1997 Mar;45(3):236-42
9087829
Lab Invest. 1996 Jul;75(1):67-76
8683941
Am J Pathol. 2002 Mar;160(3):787-94
11891177
Anticancer Res. 2007 Mar-Apr;27(2):785-91
17465203
Eur J Cancer Prev. 2001 Feb;10(1):69-75
11263593
Cancer. 1976 Jul;38(1):232-43
947518
J Virol. 2004 Feb;78(4):1697-705
14747535
Am J Pathol. 2002 Oct;161(4):1207-13
12368194
Jpn J Cancer Res. 1997 Mar;88(3):262-6
9140110
Virology. 1990 Jul;177(1):44-53
2162115
Cancer. 1994 May 1;73(9):2239-49
8168030
Br J Cancer. 1996 Aug;74(4):625-31
8761381
J Gastroenterol. 2006 Aug;41(8):733-9
16988760
Int J Cancer. 1996 Dec 11;68(6):710-5
8980171
Cancer Sci. 2003 Jan;94(1):76-80
12708478
J Virol. 1998 Oct;72(10):8321-6
9733877
Acta Pathol Jpn. 1993 Oct;43(10):574-81
8291445
J Infect. 2001 Aug;43(2):111-5
11676516
Int J Cancer. 2004 Nov 1;112(2):273-8
15352040
Mol Biol Cell. 2003 Aug;14(8):3208-15
12925757
Int J Cancer. 2005 May 20;115(1):93-7
15688413
Am J Pathol. 1998 Jan;152(1):191-8
9422536
J Pathol. 2003 Apr;199(4):447-52
12635135
Pathol Int. 1997 Jun;47(6):360-7
9211523
J Virol. 2000 Nov;74(22):10681-9
11044112
Semin Cancer Biol. 1999 Oct;9(5):369-75
10547345
Anticancer Res. 2005 Sep-Oct;25(5):3183-90
16101125
Lab Invest. 1994 Jul;71(1):73-81
8041121
Cancer. 1994 Aug 1;74(3):805-9
8039108
Hum Pathol. 2004 May;35(5):576-81
15138932
Virus Genes. 1999;19(2):103-11
10541014
Oncogene. 2004 Jun 3;23(26):4646-54
15064707
Int J Cancer. 1992 Aug 19;52(1):34-7
1323539
J Virol. 1987 May;61(5):1416-20
3033269
Cancer Lett. 2006 Jul 8;238(1):90-103
16054293
Diagn Mol Pathol. 2001 Dec;10(4):223-7
11763312
Cancer Res. 2003 Nov 1;63(21):7062-7
14612496
Scand J Gastroenterol. 2002 Jul;37(7):825-9
12190097
Gastric Cancer. 2003;6(3):173-8
14520531
J Clin Gastroenterol. 1999 Jul;29(1):39-43
10405229
J Pathol. 1997 Nov;183(3):293-8
9422984
Int J Cancer. 2003 Dec 10;107(5):866-7
14566840
Pathol Int. 2000 Jun;50(6):486-92
10886725
J Clin Pathol. 1994 Aug;47(8):695-8
7962618
Int J Cancer. 2004 Mar 20;109(2):194-9
14750169
J Med Virol. 2007 Sep;79(9):1343-8
17607773
Nat Med. 2002 Jun;8(6):594-9
12042810
Hepatogastroenterology. 1999 Mar-Apr;46(26):1214-9
10370694
Virology. 1986 Oct 15;154(1):56-66
3019008
Anticancer Res. 1996 Sep-Oct;16(5B):3081-4
8920771
Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):9131-5
8090780
J Virol. 2002 Jul;76(13):6825-31
12050395
Int J Oncol. 2005 Nov;27(5):1265-72
16211221
EMBO J. 1989 Oct;8(10):2897-903
2555151
Rinsho Byori. 1996 Dec;44(12):1196-200
8990940
Histopathology. 2000 Mar;36(3):252-61
10692029
Hepatogastroenterology. 2005 Jul-Aug;52(64):1066-70
16001631